by Megan Brown | Jan 2, 2019 | Alerts
The FDA has approved Elxonris (tagraxofusperzs) infusion to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) in patients two years and older. This is the first FDA approved therapy specifically for BPDCN. Elzonris is a targeted investigational therapy...
by Megan Brown | Jan 2, 2019 | Alerts
The injection Ultomirus (ravulizumab) has been approved for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). Ultomiris is a long-acting complement inhibitor that prevents hemolysis. Richard Pazdur, M.D., director of the FDA’s Oncology...
by Megan Brown | Dec 27, 2018 | Alerts
FDA approved ProAir digihaler by Asthmapolis, the first app-connected digital inhaler. The ProAir Digihaler has built-in sensors to detect when the device is used and the strength of the user’s inhalation. This data is then sent via Bluetooth to its mobile app...
by Megan Brown | Dec 17, 2018 | Alerts
There’s a new drug for people suffering from Chronic Idiopathic Constipation(CIC) headed to the market in 2019. The US FDA has approved Motegrity with the active ingredient Prucalopride for the treatment of CIC presented by Shire Dev LLC. Motegrity is a...
by Megan Brown | Dec 11, 2018 | Alerts
The Lancet reports the first successful live birth from a uterus transplant. In September 2016, a 32-year-old woman in Brazil with congenital uterine absence, or Mayer-Rokitansky-Küster-Hauser [MRKH] syndrome, underwent a successful uterine transplantation from a...
